Status:
UNKNOWN
Effect of Bifidobacterium on Irritable Bowel Syndrome
Lead Sponsor:
Tohoku University
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There has been no data on effect of Bifidobacterium breve on symptoms of patients with irritable bowel syndrome (IBS). We hypothesized that Bifidobacterium breve is effective on symptoms of IBS patien...
Detailed Description
There has been no data on effect of Bifidobacterium breve on symptoms of patients with irritable bowel syndrome (IBS). We hypothesized that Bifidobacterium breve is effective on symptoms of IBS patien...
Eligibility Criteria
Inclusion
- Diagnosis of IBS with Rome II definition
Exclusion
- Diagnosis of serious diseases (both physically and mentally)
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00737841
Start Date
January 1 2006
End Date
September 1 2008
Last Update
August 20 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tohoku University Graduate School of Medicine
Sendai, Miyagi, Japan, 980-8575